Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted pyrazolo[3,4-d]pyrimidines as ACK-1 and LCK inhibitors

Substituted pyrazolo[3,4-d]pyrimidines as ACK-1 and LCK inhibitors

US Patent 7763624 · Granted Jul 27, 2010

Estimated economic value: $138,127,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

3-substituted piperidine compounds for Cbl-b inhibition, and use thereof2025
Broad spectrum antiviral compositions and methods2025
KRAS G12C inhibitors and methods of using the same2025
Process of preparing 3-fluoro-5(((1R,2AR)-3,3,4,4-tetrafluoro-1,2A-dihydroxy-2,22025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
TYK2 inhibitors and uses thereof2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
CDK inhibitors2025
6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses the2025
Substituted pyrazolo[5′,1′:2,3]pyrimido[5,4-b][1,4]oxazines as TYK2 inhibitors2025